Cerity Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.5M | Buy |
|
|||||
|
2025
Q2 | $7.39M | Buy |
|
|||||
|
2025
Q1 | $3.69M | Sell |
|
|||||
|
2024
Q4 | $5.29M | Buy |
|
|||||
|
2024
Q3 | $4.5M | Buy |
|
|||||
|
2024
Q2 | $3.77M | Sell |
|
|||||
|
2024
Q1 | $3.97M | Buy |
|
|||||
|
2023
Q4 | $575K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $397K | Buy |
|
|||||
|
2023
Q1 | $390K | Buy |
|
|||||
|
2022
Q4 | $387K | Buy |
|
|||||
|
2022
Q3 | $288K | Sell |
|
|||||
|
2022
Q2 | $284K | Buy |
|